Medical AI Startup OpenEvidence Weighs $200 Million Funding Round

Medical-focused artificial intelligence startup OpenEvidence has reportedly considered raising $200 million at a $20 billion valuation. However, the company is unlikely to proceed, partly because the fundraise will dilute founders and shareholders, The Information reported Friday (July 17), citing a source involved in the discussions. That source added that OpenEvidence has also held acquisition talks with a large tech company in the last few months.